These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1498343)

  • 21. Roles of brain angiotensin II and C-type natriuretic peptide in deoxycorticosterone acetate-salt hypertension in rats.
    Nishimura M; Ohtsuka K; Sakamoto M; Nanbu A; Takahashi H; Yoshimura M
    J Hypertens; 1998 Aug; 16(8):1175-85. PubMed ID: 9794722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen metabolite 2-methoxyestradiol prevents hypertension in deoxycorticosterone acetate-salt rats.
    Yuan W; Yu Y; Li J; Singh P; Li D; Gui Y; Zheng XL
    Cardiovasc Drugs Ther; 2013 Feb; 27(1):17-22. PubMed ID: 23229845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of quinapril on expression of eNOS, ACE, and AT1 receptor in deoxycorticosterone acetate-salt hypertensive rats.
    Hara K; Kobayashi N; Watanabe S; Tsubokou Y; Matsuoka H
    Am J Hypertens; 2001 Apr; 14(4 Pt 1):321-30. PubMed ID: 11336177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emblica officinalis exerts antihypertensive effect in a rat model of DOCA-salt-induced hypertension: role of (p) eNOS, NO and oxidative stress.
    Bhatia J; Tabassum F; Sharma AK; Bharti S; Golechha M; Joshi S; Sayeed Akhatar M; Srivastava AK; Arya DS
    Cardiovasc Toxicol; 2011 Sep; 11(3):272-9. PubMed ID: 21748534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of quercetin treatment on vascular function in deoxycorticosterone acetate-salt hypertensive rats. Comparative study with verapamil.
    Galisteo M; García-Saura MF; Jiménez R; Villar IC; Wangensteen R; Zarzuelo A; Vargas F; Duarte J
    Planta Med; 2004 Apr; 70(4):334-41. PubMed ID: 15095149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of angiotensin-converting enzyme (ACE), neutral endopeptidase (NEP) and dual ACE/NEP inhibition on blood pressure and resistance arteries of deoxycorticosterone acetate-salt hypertensive rats.
    Pu Q; Touyz RM; Schiffrin EL
    J Hypertens; 2002 May; 20(5):899-907. PubMed ID: 12011651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of sesamin on altered vascular reactivity in aortic rings of deoxycorticosterone acetate-salt-induced hypertensive rat.
    Matsumura Y; Kita S; Ohgushi R; Okui T
    Biol Pharm Bull; 2000 Sep; 23(9):1041-5. PubMed ID: 10993201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic hemodynamics in non-anesthetized L-NAME- and DOCA-salt-treated mice.
    Obst M; Gross V; Luft FC
    J Hypertens; 2004 Oct; 22(10):1889-94. PubMed ID: 15361759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac and vascular responses in deoxycorticosterone acetate-salt hypertensive rats.
    Brown L; Ooi SY; Lau K; Sernia C
    Clin Exp Pharmacol Physiol; 2000 Apr; 27(4):263-9. PubMed ID: 10779123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of antihypertensive treatment and N omega-nitro-L-arginine methyl ester on cardiovascular structure in deoxycorticosterone acetate-salt hypertensive rats.
    Li JS; Sventek P; Schiffrin EL
    J Hypertens; 1996 Nov; 14(11):1331-9. PubMed ID: 8934362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-HT2B-receptor antagonist LY-272015 is antihypertensive in DOCA-salt-hypertensive rats.
    Watts SW; Fink GD
    Am J Physiol; 1999 Mar; 276(3):H944-52. PubMed ID: 10070078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt.
    Somers MJ; Mavromatis K; Galis ZS; Harrison DG
    Circulation; 2000 Apr; 101(14):1722-8. PubMed ID: 10758056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of enalapril on the endothelial function of DOCA-salt hypertensive rats.
    Nunes VW; Fortes ZB; Nigro D; Carvalho MH; Zorn TM; Scivoletto R
    Gen Pharmacol; 2000 Feb; 34(2):117-25. PubMed ID: 10974419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory effect of potassium on blood pressure in DOCA salt hypertension in rats.
    Suzuki H; Kondo K; Saruta T
    Acta Endocrinol (Copenh); 1981 Aug; 97(4):525-32. PubMed ID: 7270008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of NO and angiotensin II in the early development of endothelial functions impairment and cardiac hypertrophy in deoxycorticosterone acetate-salt hypertension.
    K-Laflamme A; Oster L; Cardinal R; de Champlain J
    Can J Physiol Pharmacol; 1998 Jun; 76(6):665-75. PubMed ID: 9923405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. (-)-Epicatechin Reduces Blood Pressure and Improves Left Ventricular Function and Compliance in Deoxycorticosterone Acetate-Salt Hypertensive Rats.
    Jackson D; Connolly K; Batacan R; Ryan K; Vella R; Fenning A
    Molecules; 2018 Jun; 23(7):. PubMed ID: 29932135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preventive effects of low molecular mass potassium alginate extracted from brown algae on DOCA salt-induced hypertension in rats.
    Chen YY; Ji W; Du JR; Yu DK; He Y; Yu CX; Li DS; Zhao CY; Qiao KY
    Biomed Pharmacother; 2010 Apr; 64(4):291-5. PubMed ID: 19932586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [DOCA-salt hypertension in cats].
    Dolgushina AD
    Biull Eksp Biol Med; 1983 Apr; 95(4):8-9. PubMed ID: 6831025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular effects of a specific nonpeptide antagonist of substance P (NK-1) receptor in DOCA-salt hypertension.
    Kohlmann O; Ginoza M; Cezaretti ML; Zanella MT; Ribeiro AB; Tavares A; Ramos OL; Leeman SE; Gavras I; Gavras H
    Hypertension; 1995 Dec; 26(6 Pt 2):1186-9. PubMed ID: 7498993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antihypertensive and antioxidant effects of protocatechuic acid in deoxycorticosterone acetate-salt hypertensive rats.
    Safaeian L; Emami R; Hajhashemi V; Haghighatian Z
    Biomed Pharmacother; 2018 Apr; 100():147-155. PubMed ID: 29428662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.